ask="15.33"
ask_size="100"
average_daily_volume="59702"
bid="14.50"
bid_size="1000"
book_value="6.38"
change="+0.16"
change_from_200_day_moving_average="-1.12"
change_from_50_day_moving_average="-1.94"
change_from_52_week_high="-5.48"
change_From_52_week_low="2.20"
change_in_percent="+1.06%"
close="15.26"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="15.65"
high_52_weeks="20.74"
last_trade_date="1/25/2017"
last_trade_price="15.26"
last_trade_size="1195"
last_trade_time="4:00pm"
low="14.60"
low_52_weeks="13.06"
market_capitalization="331.52M"
moving_average_200_day="16.38"
moving_average_50_day="17.20"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="15.10"
pe_ratio="N/A"
peg_ratio="-1.44"
percent_change_from_200_day_moving_average="-6.84%"
percent_change_from_50_day_moving_average="-11.26%"
percent_change_from_52_week_high="-26.42%"
percent_change_from_52_week_low="+16.85%"
previous_close="15.10"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.37"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="4.62"
stock_exchange="NGM"
symbol="BOLD"
volume="32798"
weeks_range_52="13.06 - 20.74"
